Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04785053 · ClinicalTrials.gov registry record · NA

Memory Functions in Mild Alzheimer's Disease

A NA study, sponsored by Hebrew SeniorLife.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT04785053 is a NA study that has completed, run by Hebrew SeniorLife. The registered enrollment target is 34 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04785053, a NA study, has completed, sponsored by Hebrew SeniorLife.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

The overall objective of this project is to examine the effects of non-invasive brain stimulation on episodic memory performance

Interventions

  • DEVICE transcranial alternating current stimulation (tACS)

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2020-06-22
Est. Completion 2023-09-30
Phase NA

Sponsor

Hebrew SeniorLife

32 total trials

What the Registry Record Tells You About NCT04785053

The ClinicalTrials.gov registry entry for NCT04785053 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hebrew SeniorLife, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which transcranial alternating current stimulation (tACS) is the first listed.

NCT04785053 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04785053 about?

NCT04785053 is a clinical study titled "Memory Functions in Mild Alzheimer's Disease". The overall objective of this project is to examine the effects of non-invasive brain stimulation on episodic memory performance

What is the current status of trial NCT04785053?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2020-06-22. Estimated completion is 2023-09-30.

What interventions are being tested in trial NCT04785053?

The interventions under investigation include: transcranial alternating current stimulation (tACS) (DEVICE).

Who is sponsoring clinical trial NCT04785053?

This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.